FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services Sucralfate Tablets Recall

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Sep 3, 2025
Recall ID
D-0598-2025
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Sucralfate Tablets starting Jul 29, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0598-2025 on Sep 3, 2025. Reason: CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated. Status: Ongoing.

Why it was recalled

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

Product description

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

Lot numbers, UPCs & expiration codes

Lot 1015038, Exp Date 07/31/2025, Lot 1015898, Exp Date 09/30/2025; Lot 1016873, Exp Date 10/31/2025 and Lot 1023398, Exp Date 07/31/2026.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0598-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jul 29, 2025
FDA report date
Sep 3, 2025
Quantity
26,992 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0598-2025, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
97361
Address
2550 John Glenn Ave Ste A
Code information
Lot 1015038, Exp Date 07/31/2025, Lot 1015898, Exp Date 09/30/2025; Lot 1016873, Exp Date 10/31/2025 and Lot 1023398, Exp Date 07/31/2026.
Postal code
43217-1188
Report date
Sep 3, 2025
Product type
Drugs
Recall number
D-0598-2025
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
26,992 blister packs
Reason for recall
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
Distribution pattern
Nationwide
Recall initiation date
Jul 29, 2025
Initial firm notification
Letter
Center classification date
Aug 22, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0598-2025, published Sep 3, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls